Inclusion of drugs on the World Health Organization 's Essential Medicines List: A game‐changer for obesity?
Diabetes, Obesity and Metabolism · 2023
DOI: 10.1111/dom.15114 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Rajmohan Seetharaman. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Seth G.S. Medical College & KEM Hospital, Mumbai, India. Hauptthemen laut MEDLINE: Drugs, Essential. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15114. Data sharing not applicable to this article as no datasets were generated or analysed during the current letter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Seth G.S. Medical College & KEM Hospital, Mumbai, India.
ORCID-Profile: Rajmohan Seetharaman
Zitieren
APA
Seetharaman, R. (2023). Inclusion of drugs on the World Health Organization 's Essential Medicines List: A game‐changer for obesity?. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15114
Vancouver
Seetharaman R. Inclusion of drugs on the World Health Organization 's Essential Medicines List: A game‐changer for obesity?. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15114
BibTeX
@article{Seetharaman2023,
author = {Seetharaman, Rajmohan},
title = {Inclusion of drugs on the World Health Organization 's Essential Medicines List: A game‐changer for obesity?},
journal = {Diabetes, Obesity and Metabolism},
year = {2023},
doi = {10.1111/dom.15114}
}
EUVIMED